Prescription Drug Product Labeling; Public Patient Education Workshop

Riepilogo

The Food and Drug Administration (FDA) is reannouncing a public patient education workshop to discuss methods and criteria for developing and evaluating prescription drug information for patients. Previously, in the Federal Register of December 8, 1995 (60 FR 63049), the agency announced this workshop which was scheduled for January 9 and 10, 1996. Due to inclement weather, the agency was forced to postpone the workshop. The agency has rescheduled the workshop for February 14 and 15, 1996. The purpose of this workshop is to obtain views and opinions concerning the criteria for useful patient information, and it is part of FDA's ongoing initiative to improve the distribution of adequate and useful prescription drug information to patients. FDA encourages health professionals, consumer groups, and other interested parties to participate in the workshop. FDA also invites the designers of primary information systems, which produce either written information or computer programs that generate prescription drug patient information, to display their systems for educational purposes.